neuraminidase

单词neuraminidase

基本解释

n.: 神经氨酸苷酶；神经氨糖酸苷酶；〔生化〕唾液酸苷酶；唾液酸耷酶
网络: 神经氨酸酶；神经胺酸酶；神经胺酶

英汉解释

• 唾液酸耷酶

• 〔生化〕唾液酸苷酶

• 神经氨糖酸苷酶

• 神经氨酸苷酶

例句

• Neuraminidase (NA) is an important protein on the surface of virion and plays an important role in immune and lethality.

  神经氨酸酶（NA）是流感病毒表面的一种重要蛋白质，在免疫和致病方面起重要作用。

• CONCLUSION Pyrrolidine derivatives exhibited potent neuraminidase inhibitory activities, and is worth of further investigation.

  结论吡咯烷类化合物对神经氨酸酶有较高的抑制活性，值得进一步研究。

• To overcome drug resistance, researchers are searching for alternative sites on neuraminidase against which new drugs can be targeted.

  为了克服耐药性，科学家正在神经氨酸酶上寻找一个替代的位置，并针对其开发新药。

• The next big target is another surface protein, neuraminidase (see "Moving target" ).

  其次是另一种表面蛋白神经氨酸酶（见“转移攻击”）。

• Zanamivir and oseltamivir bind differently at the neuraminidase catalytic site and this contributes to different drug resistance profiles.

  扎那米韦和奥塞米韦结合在神经氨酸酶的不同催化位点，这就导致了这种耐药情况不同的发生。

• The viruses showed no mutations associated with resistance to the neuraminidase inhibitors, including oseltamivir (Tamiflu).

  这些病毒显示没有与包括奥斯他韦（达菲）在内的神经氨酶抑制剂耐药性有关的突变。

• The efficacy of the neuraminidase inhibitors depends, among others, on their early administration ( within 48 hours after symptom onset).

  神经氨酸酶抑制剂的疗效特别取决于其早期使用（在症状出现后48小时之内）。

• The H5N1 virus is expected to be susceptible to the neuraminidase inhibitors.

  H5N1病毒预期对神经氨酸酶抑制剂敏感。

• "The new neuraminidase gene that came in from Eurasian swine is one we"ve never before seen circulating in humans, " said Rambaut.

  “我们以前从未在人体内见过这种出自欧亚猪的新型神经氨酸酶基因。”兰姆伯特说。

• The recent progress of the research of neuraminidase inhibitors related to sialic acid in the control of influenza is reviewed.

  对结构基于唾液酸类的神经氨酸酶抑制剂在抗流感病毒药物研究中的进展进行了综述。